[1]
|
张倩, 王花欣, 王媛, 等. 中药防治绝经后骨质疏松症的研究进展[J]. 中国骨质疏松杂志, 2020, 26(7): 1083-1088.
|
[2]
|
李微, 张博, 张雨薇, 等. 雌激素调节骨代谢作用的研究进展[J]. 中国骨质疏松杂志, 2017, 23(2): 262-266.
|
[3]
|
Gloria, B., Isabella, P., Pantaleo, G., et al. (2018) Oxidative Stress as a Possible Pathogenic Co-factor of Post-Menopausal Osteoporosis: Existing Evidence in Support of the Axis Oestrogen Deficiency-Redox Imbal-ance-Bone Loss. The Indian Journal of Medical Research, 147, 341-351. https://doi.org/10.4103/ijmr.IJMR_524_18
|
[4]
|
李丽娟, 林静, 王凌. 肠道微生态影响绝经后骨质疏松症发生发展的研究进展[J]. 中国免疫学杂志, 2019, 35(16): 2032-2037.
|
[5]
|
雷欣东, 于慧, 龙琼, 等. 绝经后骨质疏松症发病机制研究进展[J]. 中国骨质疏松杂志, 2021, 27(11): 1681-1684.
|
[6]
|
牛明, 张斯琴, 张博, 等. 《网络药理学评价方法指南》解读[J]. 中草药, 2021, 52(14): 4119-4129.
|
[7]
|
Ru, J., Li, P., Wang, J., et al. (2014) TCMSP: A Database of Systems Pharmacology for Drug Discovery from Herbal Medicines. Journal of Cheminformatics, 6, Article No. 13. https://doi.org/10.1186/1758-2946-6-13
|
[8]
|
中华中医药学会.绝经后骨质疏松症(骨痿)中医药诊疗指南(2019年版) [J].中医正骨,2020,32(2):1-13.
|
[9]
|
Elizabeth, S., David, B., Bo, A., et al. (2014) Atypical Subtrochan-teric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research. Journal of Bone and Mineral Research, 29, 1-23.
|
[10]
|
Marcea, W., Jia, G., Theresa, K. and Benson, G. (2012) Bisphosphonates for Osteoporosis—Where Do We Go from Here? The New England Journal of Medicine, 366, 2048-2051. https://doi.org/10.1056/NEJMp1202619
|
[11]
|
Vahle, J.L., Long, G.G., Sandusky, G., et al. (2004) Bone Neoplasms in F344 Rats Given Teriparatide [rhPTH(1-34)] Are Dependent on Duration of Treatment and Dose. Toxicologic Pathology, 32, 426-438.
https://doi.org/10.1080/01926230490462138
|
[12]
|
Huang, Y.Y., Wang, Z.H., Deng, L.H., Wang, H. and Zheng, Q. (2020) Oral Administration of Quercetin or Its Derivatives Inhibit Bone Loss in Animal Model of Osteoporosis. Oxida-tive Medicine and Cellular Longevity, 2020, Article ID: 6080597. https://doi.org/10.1155/2020/6080597
|
[13]
|
Kuan, S.W., Chin, K.Y. and Ima-Nirwana, S. (2019) The Osteoprotective Effects of Kaempferol: The Evidence from in vivo and in vitro Studies. Drug Design, Development and Therapy, 13, 3497-3514.
https://doi.org/10.2147/DDDT.S227738
|
[14]
|
Sajjad, J., Maryam, B., Mohammad, Z., Komaki, A. and Hajikhani, R. (2021) Effects of Intrathecal and Intracerebroventricular Microinjection of Kaempferol on Pain: Possible Mechanisms of Action. Research in Pharmaceutical Sciences, 16, 203-216. https://doi.org/10.4103/1735-5362.310527
|
[15]
|
Jing, Z., Wang, C.Y., Yang, Q.N., et al. (2019) Luteolin Attenuates Glucocorticoid-Induced Osteoporosis by Regulating ERK/Lrp-5/GSK-3β Signaling Pathway in vivo and in vitro. Journal of Cellular Physiology, 234, 4472-4490.
https://doi.org/10.1002/jcp.27252
|
[16]
|
许勇, 谢贤斐, 颜威, 等. 木犀草素调控PI3K/AKT通路改善绝经后骨质疏松症大鼠模型骨丢失的机制[J]. 热带医学杂志, 2022, 22(5): 639-643, 688, 744.
|
[17]
|
李浩亮, 李东方. 大黄素抑制miR-338-3p表达促进骨质疏松性骨折大鼠的愈合[J]. 中国组织工程研究, 2022, 26(32): 5155-5161.
|
[18]
|
杨超, 沈师, 赵露, 等. 大黄素治疗对去卵巢大鼠骨量流失的保护作用机制研究[J]. 中国骨质疏松杂志, 2021, 27(1): 60-64.
|
[19]
|
Zheng, Z., Zhang, X., Zhou, Y., et al. (2017) Anhydroicaritin, a SREBPs Inhibitor, Inhibits RANKL-Induced Osteoclastic Differentiation and Improves Diabetic Osteoporosis in STZ-Induced Mice. European Journal of Pharmacology, 809, 156-162. https://doi.org/10.1016/j.ejphar.2017.05.017
|
[20]
|
赵晓宇, 庞士龙, 徐嵩, 等. 雌激素缺乏女性糖尿病患者肿瘤坏死因子-α的表达水平及对骨质疏松的影响[J]. 中国妇幼保健, 2022, 37(15): 2869-2872.
|
[21]
|
刘树华, 王世浩, 温刘莹, 等. 绝经后妇女血清中IL-6、TNF-α、IL-27与骨质疏松的相关性[J]. 中国骨质疏松杂志, 2023, 29(4): 477-482, 530.
|
[22]
|
杜娟. 雌激素和氧化应激通过过氧化物还原酶1型调控成骨细胞功能及相关通路的研究[D]: [博士学位论文]. 济南: 山东大学, 2018.
|
[23]
|
Peng, X.D., Xu, P.Z., Chen, M.L., et al. (2003) Dwarfism, Impaired Skin Development, Skeletal Muscle Atrophy, Delayed Bone Development, and Impeded Adipogenesis in Mice Lacking Akt1 and Akt2. Genes & Development, 17, 1352-1365. https://doi.org/10.1101/gad.1089403
|
[24]
|
Zhu, G.C., Chen, W., Tang, C.Y., et al. (2022) Knockout and Double Knockout of Cathepsin K and Mmp9 Reveals a Novel Function of Cathepsin K as a Regulator of Osteoclast Gene Ex-pression and Bone Homeostasis. International Journal of Biological Sciences, 18, 5522-5538. https://doi.org/10.7150/ijbs.72211
|
[25]
|
谢兴文, 李建国, 黄晋, 等. 血管内皮生长因子防治骨质疏松的研究进展[J]. 中国骨质疏松杂志, 2019, 25(7): 1030-1033.
|
[26]
|
邓燕君, 刘博文, 贺桢翔, 等. 基于网络药理学和分子对接法探索藿香正气口服液预防新型冠状病毒肺炎(COVID-19)活性化合物研究[J]. 中草药, 2020, 51(5): 1113-1122.
|
[27]
|
孙菁. 基于AGEs/RAGE/NF-κB通路探讨培本固疏方治疗原发性骨质疏松症的作用机制[D]: [硕士学位论文]. 南京: 南京中医药大学, 2021. https://doi.org/10.27253/d.cnki.gnjzu.2020.000801
|
[28]
|
杨烙坚, 周小海, 刘力菠, 等. 补肾活血汤对去卵巢骨质疏松小鼠的干预作用研究: 基于PI3K/AKT/mTOR信号通路[J]. 亚太传统医药, 2023, 19(5): 36-41.
|
[29]
|
刘旭良, 周元敏, 曾祥英, 等. 益生菌制剂通过PI3K/Akt信号通路改善骨质疏松大鼠的骨代谢和骨量[J]. 中国骨质疏松杂志, 2022, 28(8): 1139-1144, 1153.
|
[30]
|
韩林静, 吴克亮, 杜根发, 等. 基于PI3K/Akt信号通路滋肾健骨方对去势大鼠的骨保护作用[J]. 中华骨质疏松和骨矿盐疾病杂志, 2022, 15(4): 353-361.
|
[31]
|
刘冠峤. EGFR信号通路在年龄相关性皮质骨疏松中的作用[D]: [博士学位论文]. 广州: 南方医科大学, 2021.
|